Influenza infection is one of the leading causes of morbidity and mortality worldwide, with a commensurately large impact on healthcare spending. A striking feature of influenza A viral infection is the large number of apoptotic cells that result and which must be cleared in order to maintain homeostasis. The effector mechanisms of the innate immune system are critical to the recognition and removal of these apoptotic cells. The goal of this proposal is understanding how the innate immune system facilitates clearance of influenza A virus infection-induced apoptotic cells, and more generally how the innate immune system modulates the inflammatory response in the lungs. The focus of this proposal is mannose-binding lectin (MBL), a serum protein of the innate immune system that recognizes not only pathogens, including viruses, but also altered self, such as apoptotic cells. Our preliminary data indicate that (1) Lack of MBL impairs removal of apoptotic lymphocytes in lungs, the primary organ infected by infleunza A virus; (2) MBL binds to apoptotic lymphocytes; and (3) MBL plays a key role in the modulation of inflammation. Understanding the molecular aspects of the innate immunte system in clearing infection-induced aoptotic cells and regulating the inflammatory response during the removal of apoptotic cells will provide new therapeutic approaches to treat complications from virus infection and likely other chronic lung diseases. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI077081-02
Application #
7499687
Study Section
Special Emphasis Panel (ZAI1-PA-I (S2))
Program Officer
Miller, Lara R
Project Start
2007-09-25
Project End
2010-08-31
Budget Start
2008-09-01
Budget End
2010-08-31
Support Year
2
Fiscal Year
2008
Total Cost
$205,541
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Takahashi, Kazue; Saha, Dalia; Shattino, Ivany et al. (2011) Complement 3 is involved with ventilator-induced lung injury. Int Immunopharmacol 11:2138-43
Michelow, Ian C; Lear, Calli; Scully, Corinne et al. (2011) High-dose mannose-binding lectin therapy for Ebola virus infection. J Infect Dis 203:175-9
Chang, Wei-Chuan; Hartshorn, Kevan L; White, Mitchell R et al. (2011) Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol 81:388-95
Takahashi, Kazue; Chang, Wei-Chuan; Takahashi, Minoru et al. (2011) Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology 216:96-102
Takahashi, Kazue (2011) Mannose-binding lectin and the balance between immune protection and complication. Expert Rev Anti Infect Ther 9:1179-90
Rohrer, Bärbel; Coughlin, Beth; Kunchithapautham, Kannan et al. (2011) The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization. Mol Immunol 48:e1-8
Chang, Wei-Chuan; White, Mitchell R; Moyo, Patience et al. (2010) Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection. BMC Immunol 11:64
Renner, Brandon; Strassheim, Derek; Amura, Claudia R et al. (2010) B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion. J Immunol 185:4393-400
Michelow, Ian C; Dong, Mingdong; Mungall, Bruce A et al. (2010) A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J Biol Chem 285:24729-39